Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Burak Ozgur

Neurological Surgery Irvine, CA Medical Doctor

NPI 1205877651 CMS profile 327034

16405 Sand Canyon Ave Ste 200, Ste 200, Irvine, CA 92618

Open in the dashboard

General payments

$418,223

231 records reported · program years 2019–2025

Research payments

$117,288

Paid to them · 16 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$36,825 paid to institutions, not to them · program year 2024

Through program year 2025, Burak Ozgur of Irvine, CA is reported in the CMS Open Payments database as having received $418,223 across 231 general payments and $117,288 in research payments paid to them. Separately, studies naming them as principal investigator received $36,825 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 97th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

12 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $18,640 18
2025 Research $24,650 4
2024 General $11,302 10
2024 Research $38,325 5
2023 General $43,371 34
2023 Research $38,314 5
2022 General $77,682 38
2021 General $97,144 47
2021 Research $5,000 1
2020 General $80,320 35
2020 Research $11,000 1
2019 General $89,764 49

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Burak Ozgur
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Burak Ozgur were reported at $18,640. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Burak Ozgur Neurological Surgery median Middle half National median
2019 $89,764 $582 $138–$3,006 $163
2020 $80,320 $294 $76–$2,174 $114
2021 $97,144 $387 $105–$2,432 $132
2022 $77,682 $542 $139–$2,989 $149
2023 $43,371 $534 $145–$2,697 $160
2024 $11,302 $574 $155–$3,046 $164
2025 $18,640 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Globus Medical, Inc. $188,911 64 payments
  2. Spinal Elements, Inc. $137,230 40 payments
  3. Spineart USA Inc $32,313 32 payments
  4. Nexxt Spine LLC $18,638 11 payments
  5. Zimmer Biomet Holdings, Inc. $9,725 6 payments
  6. GS Solutions, Inc. $9,058 5 payments
  7. Spineart SA $7,565 2 payments
  8. Medical Device Business Services, Inc. $3,013 2 payments
  9. Surgical Theater. Inc. $2,817 2 payments
  10. 7D Surgical Inc. $2,733 6 payments
  11. Other $6,220 61 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $293,323 70 payments
  2. Consulting Fee $99,550 31 payments
  3. Travel and Lodging $15,493 25 payments
  4. Food and Beverage $9,297 102 payments
  5. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $486 2 payments
  6. Gift $75 1 payment
Products named General payments · program years 2019–2025
  1. CALIBER Spine $109,301 10 payments
  2. Lucent Lateral $58,037 13 payments
  3. CALIBER Spine/Joint $32,303 4 payments
  4. Lucent $31,988 4 payments
  5. CLUTCH $24,950 10 payments
  6. CALIBER Spine/Spine Surgery $24,711 6 payments
  7. Medical Devices $17,875 4 payments
  8. Nexxt Matrixx Products $17,443 3 payments
  9. SCARLET $16,200 2 payments
  10. SA ALIF System $13,299 2 payments
  11. Other $80,965 151 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Spinal Elements, Inc. $99,788 13 payments
  2. GS Solutions, Inc. $17,500 3 payments

Billing to Medicare

Part B · data year 2024 · 23 billing codes

Paid by Medicare

$164,648

Medicare's payments for the services billed

Medicare patients

336

Average age 75

Services billed

744

179 women, 157 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 73%
Ischemic heart disease 27%
Osteoporosis 24%
Depression 23%
Cancer 20%
Diabetes 18%
Atrial fibrillation 15%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

247 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record